8-K//Current report
Silo Pharma, Inc. 8-K
Accession 0001213900-25-102222
$SILOCIK 0001514183operating
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:39 PM ET
Size
221.0 KB
Accession
0001213900-25-102222
Documents
- 8-Kea0262461-8k_silopharma.htmPrimary
CURRENT REPORT
- EX-10.1ea026246101ex10-1_silopharma.htm
FIRST AMENDMENT TO THE SILO PHARMA, INC. AMENDED AND RESTATED 2020 OMNIBUS EQUITY INCENTIVE PLAN
- EX-101.SCHsilo-20251024.xsd
XBRL SCHEMA FILE
- EX-101.LABsilo-20251024_lab.xml
XBRL LABEL FILE
- EX-101.PREsilo-20251024_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-102222-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0262461-8k_silopharma_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Silo Pharma, Inc.
CIK 0001514183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001514183
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:39 PM ET
- Size
- 221.0 KB